Salah-Eddin Al-Batran

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Salah-Eddin Al-Batran
Jun 6, 2025, 07:19 | Opinion
Loay Kassem: 11 Pivotal Trials From ASCO 2025 Published in The NEJM
Loay Kassem, Assistant Professor of Clinical Oncology at Kasr AlAiny School of Medicine, shared a post…
Apr 21, 2025, 08:36 | Opinion
Salah-Eddin Al-Batran: A perspective on aspirin as an adjuvant therapy
Salah-Eddin Al-Batran, Director of the Frankfurt Institute of Clinical Cancer Research, shared a post on…
Dec 29, 2024, 10:11 | Science
Salah-Eddin Al-Batran: The Deleterious Effect of Antioxidant Vitamins for Cancer Prevention
Salah-Eddin Al-Batran, Director Institute of Clinical Research UCT-University Cancer Center, shared a post on LinkedIn:…
Oct 26, 2024, 12:41 | Blog
Lucjan Wyrwicz at CSCO on modern and future treatment of gastric cancer
Lucjan Wyrwicz, Head of Department, Dept. of Oncology and Radiotherapy, Maria Skłodowska-Curie Memorial Cancer Center,…
Sep 2, 2024, 17:04 | Blog
Salah-Eddin Al-Batran: EUCAN Preceptorship on gastroesophageal cancers
Salah-Eddin Al-Batran, Director Institute of Clinical Research UCT-University Cancer Center, shared a post on LinkedIn:…
May 10, 2024, 17:49 | Drugs
Piotr Wysocki: Relatlimab does not improve the activity of nivolumab plus chemotherapy
Piotr Wysocki recently posted on LinkedIn: "RELATIVITY-060 was an open-label phase II study investigating the…
Nov 21, 2023, 02:13 | Blog
Salah-Eddin Al-Batran: Our group is happy to announce the publication of the IKF-633/DANTE trial (phase 2 portion) in Journal of Clinical Oncology
Salah-Eddin Al-Batran, Director of IKF-The Frankfurt Institute of Clinical Cancer Research, shared on LinkedIn: "Dear…
Oct 2, 2023, 18:29 | Insight
Salah-Eddin Al-Batran: I extend my warmest congratulations to my friends and colleagues Claus Rödel and Emmanouil Fokas as well as all members, investigators and study nurses of the German Rectal Cancer Study Group, for successfully completing their 18.1 trial.
All: 8 Posts: 1 - 100
Special Coverage